Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | VIR |
---|---|---|
09:32 ET | 15224 | 11.67 |
09:34 ET | 1719 | 11.77 |
09:36 ET | 37507 | 11.79 |
09:38 ET | 1700 | 11.77 |
09:39 ET | 555 | 11.74 |
09:41 ET | 3050 | 11.76 |
09:43 ET | 13676 | 11.7123 |
09:45 ET | 28533 | 11.63 |
09:48 ET | 21177 | 11.635 |
09:50 ET | 18576 | 11.59 |
09:52 ET | 46682 | 11.52 |
09:54 ET | 130236 | 11.375 |
09:56 ET | 49298 | 11.09 |
09:57 ET | 2900 | 11.205 |
09:59 ET | 5201 | 11.3 |
10:01 ET | 6710 | 11.33 |
10:03 ET | 1959 | 11.49 |
10:06 ET | 6555 | 11.4215 |
10:08 ET | 31237 | 11.31 |
10:10 ET | 4926 | 11.3 |
10:12 ET | 4390 | 11.3 |
10:14 ET | 2931 | 11.3 |
10:15 ET | 6651 | 11.38 |
10:17 ET | 6819 | 11.37 |
10:19 ET | 6176 | 11.42 |
10:21 ET | 2710 | 11.43 |
10:24 ET | 1433 | 11.42 |
10:26 ET | 7288 | 11.5 |
10:28 ET | 9611 | 11.505 |
10:30 ET | 2819 | 11.54 |
10:32 ET | 495 | 11.555 |
10:33 ET | 700 | 11.555 |
10:35 ET | 1400 | 11.53 |
10:37 ET | 2194 | 11.52 |
10:39 ET | 19516 | 11.54 |
10:42 ET | 1850 | 11.58 |
10:44 ET | 3754 | 11.56 |
10:46 ET | 834 | 11.54 |
10:48 ET | 2383 | 11.5905 |
10:50 ET | 4329 | 11.62 |
10:51 ET | 1968 | 11.61 |
10:53 ET | 1498 | 11.61 |
10:55 ET | 5003 | 11.55 |
10:57 ET | 2304 | 11.53 |
11:00 ET | 15594 | 11.52 |
11:02 ET | 11302 | 11.43 |
11:04 ET | 92668 | 11.425 |
11:06 ET | 900 | 11.42 |
11:08 ET | 100 | 11.41 |
11:09 ET | 4307 | 11.47 |
11:11 ET | 4000 | 11.46 |
11:13 ET | 3828 | 11.5285 |
11:15 ET | 7597 | 11.4709 |
11:18 ET | 4462 | 11.485 |
11:20 ET | 5495 | 11.47 |
11:22 ET | 2687 | 11.43 |
11:24 ET | 1621 | 11.45 |
11:26 ET | 2784 | 11.525 |
11:27 ET | 700 | 11.525 |
11:29 ET | 2352 | 11.5138 |
11:31 ET | 683 | 11.5141 |
11:36 ET | 2846 | 11.5 |
11:38 ET | 700 | 11.445 |
11:40 ET | 1294 | 11.4683 |
11:42 ET | 200 | 11.471 |
11:45 ET | 2522 | 11.43 |
11:47 ET | 500 | 11.42 |
11:49 ET | 393 | 11.46 |
11:51 ET | 300 | 11.461 |
11:54 ET | 3700 | 11.45 |
11:56 ET | 1100 | 11.43 |
11:58 ET | 619 | 11.43 |
12:00 ET | 300 | 11.44 |
12:02 ET | 2075 | 11.41 |
12:03 ET | 5166 | 11.36 |
12:05 ET | 600 | 11.365 |
12:07 ET | 6022 | 11.38 |
12:09 ET | 1736 | 11.38 |
12:12 ET | 30604 | 11.375 |
12:14 ET | 9171 | 11.31 |
12:16 ET | 1500 | 11.33 |
12:18 ET | 1623 | 11.3 |
12:20 ET | 16861 | 11.325 |
12:21 ET | 6571 | 11.26 |
12:23 ET | 3464 | 11.28 |
12:25 ET | 295 | 11.28 |
12:27 ET | 690 | 11.285 |
12:30 ET | 8035 | 11.19 |
12:32 ET | 1291 | 11.205 |
12:34 ET | 2498 | 11.175 |
12:36 ET | 3394 | 11.16 |
12:38 ET | 200 | 11.17 |
12:39 ET | 3695 | 11.17 |
12:41 ET | 10122 | 11.12 |
12:43 ET | 1869 | 11.14 |
12:45 ET | 1217 | 11.17 |
12:48 ET | 5535 | 11.1 |
12:50 ET | 2780 | 11.1 |
12:52 ET | 3064 | 11.12 |
12:54 ET | 12225 | 11.02 |
12:56 ET | 4944 | 11.06 |
12:57 ET | 2453 | 11.08 |
12:59 ET | 1347 | 11.0849 |
01:01 ET | 3093 | 11.08 |
01:03 ET | 5139 | 11.11 |
01:06 ET | 3058 | 11.2 |
01:08 ET | 1186 | 11.205 |
01:10 ET | 2068 | 11.2049 |
01:12 ET | 8200 | 11.23 |
01:14 ET | 6658 | 11.22 |
01:15 ET | 35075 | 11.15 |
01:17 ET | 5015 | 11.18 |
01:19 ET | 1132 | 11.21 |
01:21 ET | 1259 | 11.27 |
01:24 ET | 1401 | 11.31 |
01:26 ET | 2430 | 11.3082 |
01:28 ET | 886 | 11.28 |
01:30 ET | 6113 | 11.259 |
01:32 ET | 1290 | 11.245 |
01:33 ET | 41912 | 11.29 |
01:35 ET | 252 | 11.31 |
01:37 ET | 591 | 11.29 |
01:39 ET | 3720 | 11.26 |
01:42 ET | 400 | 11.25 |
01:44 ET | 200 | 11.25 |
01:46 ET | 1033 | 11.25 |
01:48 ET | 2205 | 11.3 |
01:50 ET | 800 | 11.26 |
01:51 ET | 3346 | 11.25 |
01:53 ET | 300 | 11.26 |
01:55 ET | 3300 | 11.24 |
01:57 ET | 58042 | 11.195 |
02:00 ET | 6357 | 11.19 |
02:02 ET | 3662 | 11.21 |
02:04 ET | 1500 | 11.23 |
02:06 ET | 4829 | 11.205 |
02:08 ET | 1199 | 11.25 |
02:09 ET | 1300 | 11.25 |
02:11 ET | 327 | 11.26 |
02:13 ET | 1603 | 11.25 |
02:15 ET | 1930 | 11.21 |
02:18 ET | 2161 | 11.205 |
02:20 ET | 2717 | 11.24 |
02:22 ET | 1500 | 11.275 |
02:24 ET | 100 | 11.28 |
02:26 ET | 3479 | 11.22 |
02:27 ET | 2304 | 11.24 |
02:29 ET | 1100 | 11.215 |
02:31 ET | 2170 | 11.22 |
02:33 ET | 2313 | 11.23 |
02:36 ET | 26795 | 11.24 |
02:38 ET | 3800 | 11.15 |
02:40 ET | 781 | 11.145 |
02:42 ET | 2593 | 11.16 |
02:44 ET | 5129 | 11.15 |
02:45 ET | 4680 | 11.1699 |
02:47 ET | 7339 | 11.17 |
02:49 ET | 7154 | 11.195 |
02:51 ET | 1410 | 11.215 |
02:54 ET | 2400 | 11.27 |
02:56 ET | 3468 | 11.25 |
02:58 ET | 1127 | 11.22 |
03:00 ET | 5533 | 11.2 |
03:02 ET | 4785 | 11.185 |
03:03 ET | 19088 | 11.2 |
03:05 ET | 21468 | 11.205 |
03:07 ET | 5079 | 11.195 |
03:09 ET | 2304 | 11.215 |
03:12 ET | 27616 | 11.14 |
03:14 ET | 4990 | 11.14 |
03:16 ET | 9427 | 11.165 |
03:18 ET | 5127 | 11.175 |
03:20 ET | 6936 | 11.18 |
03:21 ET | 10590 | 11.169 |
03:23 ET | 6584 | 11.179 |
03:25 ET | 25548 | 11.195 |
03:27 ET | 6788 | 11.2 |
03:30 ET | 43896 | 11.14 |
03:32 ET | 9636 | 11.175 |
03:34 ET | 3481 | 11.18 |
03:36 ET | 4953 | 11.22 |
03:38 ET | 5170 | 11.21 |
03:39 ET | 5128 | 11.2 |
03:41 ET | 8064 | 11.21 |
03:43 ET | 1950 | 11.22 |
03:45 ET | 10788 | 11.245 |
03:48 ET | 7563 | 11.27 |
03:50 ET | 6616 | 11.25 |
03:52 ET | 3504 | 11.27 |
03:54 ET | 62435 | 11.21 |
03:56 ET | 21655 | 11.23 |
03:57 ET | 124518 | 11.225 |
03:59 ET | 82999 | 11.23 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Vir Biotechnology Inc | 1.7B | -2.8x | --- |
Arvinas Inc | 1.9B | -4.4x | --- |
Ardelyx Inc | 1.7B | -22.4x | --- |
Immatics NV | 1.4B | -12.4x | --- |
Kymera Therapeutics Inc | 2.1B | -13.2x | --- |
Arcus Biosciences Inc | 1.5B | -5.0x | --- |
Vir Biotechnology, Inc. is an immunology company, which is focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions. The Company's clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). It also has several preclinical candidates in its pipeline including those targeting influenza A and B, COVID-19, respiratory syncytial virus and human metapneumovirus (RSV and MPV), and human papillomavirus (HPV). The Company's pipeline includes VIR-1949, VIR-7229, VIR-2981, VIR-8190, and HIV Cure. It also engaged in developing tobevibart, a monoclonal antibody also known as VIR-3434, and Elebsiran, an siRNA also known as VIR-2218, for the treatment and suppression of chronic HDV. Its Elebsiran is an investigational HBV-targeted siRNA that reduces HBsAg, a protein which is required for the HDV viral life cycle.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.7B |
---|---|
Revenue (TTM) | $79.6M |
Shares Outstanding | 136.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.51 |
EPS | $-4.01 |
Book Value | $11.80 |
P/E Ratio | -2.8x |
Price/Sales (TTM) | 21.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -780.18% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.